Study at a glance
What was studied?
Does vitamin D in early life affect developing immune cells or later childhood illness? The review compares an animal experiment with five independent human research programmes.
What did the studies find?
A mouse study found changes in developing blood-forming cells and their descendants. Two pregnancy trials did not show a clear breathing-related benefit at six years from higher supplementation. A higher infant regimen did not reduce overall reported infections. Two observational programmes gave different results for vitamin D status and an immune response linked to type 1 diabetes.
What does this mean?
Experimental cell changes, childhood illnesses and disease-risk markers answer different questions. The evidence does not establish that higher supplementation improves every part of immune development or prevents childhood immune disease.
What are the limits?
The human studies did not directly measure normal immune maturation. An association with vitamin D status does not prove prevention. Animal results do not establish the same effect in children. Some supplementary material was unavailable.
Read the full article below ↓Researchers ask whether vitamin D in early life affects developing immune cells or changes the risk of later illness. These are related questions, but they need different kinds of evidence. This summary compares an animal experiment with human studies of childhood breathing problems, infections and an immune response linked to type 1 diabetes. The findings do not establish that vitamin D determines a child’s future immune health. For the detailed evidence review, read Early-Life Vitamin D and Childhood Immune Trajectories: Full Evidence Review.
What evidence was examined?
The detailed review includes five independent human research programmes. COPSAC and VDAART tested vitamin D during pregnancy and followed children’s respiratory health. VIDI tested two vitamin D3 regimens during infancy. TEDDY and DAISY observed vitamin D status or intake and later immune-related outcomes.
These studies did not directly measure every stage of normal immune development. Vitamin D and Innate Responses: Recognition, Peptides and Function: Full Evidence Review explains why immune signals and defence functions need separate measurements. A separate mouse study by Oh and colleagues examined changes in developing blood-forming cells and their descendants. This supplies experimental evidence about developmental immune-cell programming, but it does not establish the same process in children.
What did the animal experiment show?
The mouse experiment compared cells from offspring exposed to different maternal vitamin D conditions. The cell preparations contained stem cells and other early blood-forming cells. Their descendants included macrophages, immune cells that also act within body tissues.
After transfers into adult mice, the researchers observed differences in macrophage behaviour and metabolic outcomes. This supports a developmental effect under those experimental conditions. However, the original cell populations differed in their composition. The result cannot be assigned confidently to a change in one identical cell type.
The study also examined cells from 30 human cord-blood samples. It did not follow those children to establish later immune development or disease. The findings do not prove permanent damage, or that supplementation prevents childhood diabetes. Vitamin D and Lasting Gene Regulation: Full Evidence Review explores what evidence is needed to establish a lasting biological response.
Did pregnancy supplementation prevent breathing problems?
The six-year COPSAC follow-up recorded asthma in 23 of 274 children in the higher-dose group and 18 of 268 in the comparison group. This did not establish a preventive benefit. The uncertainty was wide enough that the result also cannot prove harm or exact equality between the regimens.
VDAART followed children whose parents had a history of allergic disease. By six years, asthma or repeated wheezing occurred in 176 of 405 children in the higher-dose group and 184 of 401 in the comparison group. The main analysis did not show a clear difference.
These trials tested pregnancy regimens, not every possible timing or childhood intervention. Their six-year reports are follow-ups of the original trials, not new independent trials. The VDAART appendix was unavailable for this review, so detailed supplementary claims were not assessed.
Did a higher infant dose reduce infections?
VIDI compared two vitamin D3 regimens from about two weeks to two years of age in Finland. The infants were healthy and born at term, meaning they were not born prematurely, and almost all had sufficient vitamin D at birth by the study’s definition.
The higher regimen increased vitamin D blood levels but did not reduce the overall rate of reported infections. Parents recorded the illnesses, so these were not all laboratory-confirmed infections. The findings should not be assumed to describe severely deficient infants or infants born early.
This result separates a blood measurement from a health outcome. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains the different blood markers used in vitamin D research. Raising the measured vitamin D level did not necessarily improve the outcome being studied. Infection counts also do not describe every part of immune development.
What about immune changes linked to diabetes?
TEDDY and DAISY studied children at increased risk of type 1 diabetes. They examined islet autoimmunity: an immune response against insulin-producing tissue in the pancreas. This is not the same as a diagnosis of diabetes.
TEDDY found that higher measured vitamin D status was associated with lower odds of this immune response. Its first infant samples were taken at three, six or nine months, not at birth. The association does not prove that raising a child’s blood level prevents disease.
DAISY did not find a clear association between measured vitamin D status and these outcomes. The studies differed in their measurements and precision. Their disagreement means the observational evidence should not be presented as settled. DAISY’s missing-sample supplement was not available, limiting assessment of that issue.
What can families take from this evidence?
Experimental developmental changes, illness counts and disease-risk markers should remain separate. The animal study supports a specific developmental phenomenon. The human studies do not establish a general benefit from higher supplementation or a blood target that prevents immune disease.
For current UK guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.
Scientific sources
Oh J and colleagues. Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Nature Communications. 2023;14:3278. DOI: 10.1038/s41467-023-38849-z.
Brustad N and colleagues. High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years. JAMA. 2019;321:1003 to 1005. DOI: 10.1001/jama.2019.0052.
Litonjua AA and colleagues. Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. New England Journal of Medicine. 2020;382:525 to 533. DOI: 10.1056/NEJMoa1906137. Principal report assessed; appendix unavailable.
Rosendahl J and colleagues. Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy Infants: A Randomized Clinical Trial. JAMA Pediatrics. 2018;172:646 to 654. DOI: 10.1001/jamapediatrics.2018.0602.
Norris JM and colleagues. Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes. 2018;67:146 to 154. DOI: 10.2337/db17-0802.
Simpson M and colleagues. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54:2779 to 2788. DOI: 10.1007/s00125-011-2278-2. Principal report assessed; missing-sample supplement unavailable.
Related reading
Association of environmental markers with childhood type 1 diabetes mellitus revealed by a long questionnaire on early life exposures and lifestyle in a case-control study
The purpose of the study was to unravel environmental markers associated with T1D.
Original paper ↗Read more →Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study
Participants commonly reported delayed or missed diagnosis, with early symptoms such as bowed legs and short stature often misattributed to nutritional or growth-related issues, leading to late referral to specialist care.
Original paper ↗Read more →Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Environmental factors may alter the fetal genome to cause metabolic diseases.
Original paper ↗Read more →Prenatal or Childhood Serum Levels of Vitamin D and Dental Caries in Paediatric Patients: A Systematic Review
To assess the association between low prenatal or childhood levels of 25-hydroxyvitamin D (25(OH) D) and dental caries experience in children.
Original paper ↗Read more →Early-Life Vitamin D and Childhood Immune Trajectories: Full Evidence Review
Trials and cohorts on early vitamin D exposure, asthma, infection and autoimmunity, separating clinical risks from measured immune development.
Read more →Nonlinear and sex-specific associations of maternal vitamin D in early: and mid-pregnancy with childhood growth trajectories from birth to 6 years of age: a prospective cohort study in China
To examine the associations of maternal vitamin D (VitD) concentrations in early: and mid-pregnancy with offspring growth trajectories from birth to 6 years of age, as well as childhood overweight.
Original paper ↗Read more →Association of Colecalciferol, Ferritin, and Anemia among Pregnant Women: Result from Cohort Study on Vitamin D Status and Its Impact during Pregnancy and Childhood in Indonesia
Our objective was to determine if 25(OH) vitamin D (colecalciferol) status was associated with ferritin, anemia, and its changes during pregnancy.
Original paper ↗Read more →Association of first trimester maternal vitamin D, ferritin and hemoglobin level with third trimester fetal biometry: result from cohort study on vitamin D status and its impact during pregnancy and childhood in Indonesia
The aim of this study was to explore the association between maternal vitamin D level in the first trimester and fetal biometry in the later stage of pregnancy with adjusted OR for other determinants like hemoglobin and ferritin level.
Original paper ↗Read more →Atopic heredity modifies the association between maternal vitamin D status in pregnancy and the risk of atopic disease in childhood: an observational study
Thus, the aim was to investigate the associations between maternal vitamin D status and intake in pregnancy with asthma, eczema and food allergies in the children up to 5 years.
Original paper ↗Read more →Bone mineral density at age 7 years does not associate with adherence to vitamin D supplementation guidelines in infancy or vitamin D status in pregnancy and childhood: an Odense Child Cohort study
Vitamin D supplementation in infancy is recommended to prevent rickets.
Original paper ↗Read more →Enamel Defects in Deciduous Dentition and Their Association with the Occurrence of Adverse Effects from Pregnancy to Early Childhood
In a cross-sectional study, 152 children with an average age of 3.57 ± 1.25 years were examined according to the criteria established by the DDE index.
Original paper ↗Read more →Exposure to Vitamin D Fortification Policy in Prenatal Life and the Risk of Childhood Asthma: Results from the D-Tect Study
The objective of this study was to examine if children born to women exposed to the margarine fortification policy with a small dose of extra vitamin D during pregnancy had a reduced risk of developing asthma until age 9 years, compared to children born to unexposed women.
Original paper ↗Read more →Impact of a Prenatal Vitamin D Supplementation Program on Vitamin D Deficiency, Rickets and Early Childhood Caries in an Alaska Native Population
We evaluated the impact of routine prenatal vitamin D supplementation initiated in Alaska’s Yukon Kuskokwim Delta in Fall 2016.
Original paper ↗Read more →Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic
The aim of this study is to analyze the influence of SARS-CoV-2 virus on initial manifestation of T1D and patterns of risk factors for disease development in children.
Original paper ↗Read more →Maternal adherence to the EAT-Lancet diet recommendations among pregnant women in Ireland and associations with offspring birth outcomes and childhood adiposity
We investigated adherence to EAT-Lancet diet recommendations during pregnancy and associations with offspring birth outcomes and childhood adiposity.
Original paper ↗Read more →Maternal Diet Associates with Offspring Bone Mineralization, Fracture Risk and Enamel Defects in Childhood and Influences the Prenatal Effect of High-Dose Vitamin D Supplementation
Here, we investigated the effect of maternal dietary patterns during pregnancy on the risk of bone fractures, bone mineralization and enamel defects until age 6 years in the offspring.
Original paper ↗Read more →Prenatal exposure to vitamin D from fortified margarine and risk of fractures in late childhood: period and cohort results from 222 000 subjects in the D-tect observational study
By means of a nationwide mandatory vitamin D fortification programme, we examined the risk of fractures among 10 to 18-year-old children from proximate birth cohorts born around the date of the termination of the programme.
Original paper ↗Read more →Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials
We recently published two independent randomized controlled trials of vitamin D supplementation during pregnancy, both indicating a >20% reduced risk of asthma/recurrent wheeze in the offspring by 3 years of age.
Original paper ↗Read more →The Association between Maternal 25-Hydroxyvitamin D Concentration during Gestation and Early Childhood Cardio-metabolic Outcomes: Is There Interaction with Pre-Pregnancy BMI?
Therefore, this study investigated the role of pBMI in the association between maternal 25OHD concentration and cardio-metabolic outcomes in 5-6 year old children.
Original paper ↗Read more →The Association Between Prenatal Infection and Adolescent Behavior: Investigating Multiple Prenatal, Perinatal, and Childhood Second Hits
We investigated maternal lifestyle and nutrition, perinatal factors (placental health and delivery outcomes), and child health (lifestyle, traumatic events, infections) as mediators and moderators.
Original paper ↗Read more →A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes
>50% of patients with new-onset type 1 diabetes (T1D) do not enter partial clinical remission (PCR); early identification of these patients may improve initial glycemic control and reduce long-term complications.
Original paper ↗Read more →Original sources
Vitamins for children
For current UK guidance, see NHS Vitamins for children.
Publication details
For current UK guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Published in Nature Communications (2023).
Publication details
Oh J and colleagues. Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Nature Communications. 2023;14:3278. DOI: 10.1038/s41467-023-38849-z.
High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years
Published in JAMA. 2019;321:1003 to 1005. DOI: 10.1001/jama (2019).
Publication details
Brustad N and colleagues. High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years. JAMA. 2019;321:1003 to 1005. DOI: 10.1001/jama.2019.0052.
Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction
Published in New England Journal of Medicine (2020).
Publication details
Litonjua AA and colleagues. Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. New England Journal of Medicine. 2020;382:525 to 533. DOI: 10.1056/NEJMoa1906137. Principal report assessed; appendix unavailable.
Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy Infants: A Randomized Clinical Trial
Published in JAMA Pediatrics (2018).
Publication details
Rosendahl J and colleagues. Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy Infants: A Randomized Clinical Trial. JAMA Pediatrics. 2018;172:646 to 654. DOI: 10.1001/jamapediatrics.2018.0602.
Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity
Published in Diabetes (2018).
Publication details
Norris JM and colleagues. Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes. 2018;67:146 to 154. DOI: 10.2337/db17-0802.
No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
Published in Diabetologia (2011).
Publication details
Simpson M and colleagues. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54:2779 to 2788. DOI: 10.1007/s00125-011-2278-2. Principal report assessed; missing-sample supplement unavailable.